Use of Hepatitis C Virus (HCV) Immunoglobulin G Antibody Avidity as a Biomarker to Estimate the Population-Level Incidence of HCV Infection

Background. Sensitive methods are needed to estimate the population-level incidence of hepatitis C virus (HCV) infection. Methods. We developed an HCV immunoglobulin G (IgG) antibody avidity assay by modifying the Ortho 3.0 HCV enzyme-linked immunoassay and tested 997 serum or plasma samples from 56...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Infect Dis
Autori principali: Patel, Eshan U., Cox, Andrea L., Mehta, Shruti H., Boon, Denali, Mullis, Caroline E., Astemborski, Jacquie, Osburn, William O., Quinn, Jeffrey, Redd, Andrew D., Kirk, Gregory D., Thomas, David L., Quinn, Thomas C., Laeyendecker, Oliver
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2016
Soggetti:
Major Articles and Brief Reports
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4936640/
https://ncbi.nlm.nih.gov/pubmed/26768250
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiw005
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi